Trump administration talks lift REX Drone ETF 15%

Discussions within the Trump administration about direct federal funding for U.S. drone manufacturers propelled the REX Drone ETF (DRNZ) about 15% today. The ETF’s gain raised its year-to-date return to roughly 35%.

Administration officials are negotiating funding arrangements with a select group of domestic unmanned aerial vehicle makers tied to the Pentagon’s Drone Dominance program, a $1.1 billion initiative to build 300,000 low-cost attack drones by the end of next year. Proposed financing would use a mix of debt and equity and could give the federal government an ownership stake in companies chosen for support.

The prospect of federal capital and clearer prospects for Pentagon procurement increased buying interest in DRNZ, which tracks the VettaFi Drone Index and bundles micro- and mid-cap drone industry firms. The fund’s concentrated structure means major developments at a single holding can move the ETF’s price sharply.

Unusual Machines Inc. (UMAC) was identified by Pentagon planners as a primary candidate for potential backing and makes up roughly 5% of DRNZ’s top ten holdings. UMAC’s shares rose more than 60% on the session, lifting its year-to-date return to about 136%.

UMAC reported a 296% year-over-year revenue increase in the first quarter of 2026. The company completed a public offering, announced a $75 million strategic materials purchase and agreed to acquire battery specialist Upgrade Energy for $52 million, actions the company described as intended to support rapid scaling.

Other DRNZ constituents that drew buyer interest include Ondas Holdings (ONDS), AeroVironment (AVAV) and Red Cat Holdings (RCAT). Those firms supply hardware, communications systems and full UAV platforms that could participate in expanded Pentagon procurement and linked domestic manufacturing.

VettaFi is the index provider for the VettaFi Drone Index and receives a licensing fee. VettaFi is not involved in the ETF’s issuance or management.

The discussions are ongoing and subject to negotiation, internal review and any required approvals. Final funding agreements, including company selections and financial terms, could require additional approvals up to and including congressional sign-off depending on the mechanism used.